Mitigation of radiation injuries via suppression of the renin-angiotensin system: Emphasis on radiation nephropathy

Current Drug Targets

Volumn 11, Issue 11, 2010, Pages 1423-1429

  Cohen, E P ^a   Fish, B L ^a   Moulder, J E ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Angiotensins; Captopril; Mesangiolysis; Radiation injuries; Radiation nephropathy; Renin angiotensin system

Indexed keywords

ALDOSTERONE; ANGIOTENSIN[1-7]; ANGIOTENSIN[1-7][7 DEXTRO ALANINE]; BRADYKININ; CAPTOPRIL; LOSARTAN; LOSARTAN POTASSIUM; N ETHYLCARBAMOYL 3 [4 (5 FORMYL 4 METHOXY 2 PHENYL 1 IMIDAZOLYLMETHYL)PHENYL] 5 ISOBUTYL 2 THIOPHENESULFONAMIDE; SERASPENIDE; SPIRONOLACTONE; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ARTICLE; GLOMERULOPATHY; HUMAN; KIDNEY DISEASE; MICROANGIOPATHY; NONHUMAN; PATHOGENESIS; RADIATION DOSE; RADIATION INJURY; RADIATION NEPHROPATHY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; UREMIA; WHOLE BODY RADIATION; ANIMAL; DRUG EFFECT; KIDNEY; RADIATION EXPOSURE; REVIEW;

ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; HUMANS; KIDNEY; KIDNEY DISEASES; RADIATION INJURIES; RENIN-ANGIOTENSIN SYSTEM;

EID: 78649985989     PISSN: 13894501     EISSN: 18735592     Source Type: Journal    
DOI: 10.2174/1389450111009011423     Document Type: Article

References (49)

1. Antignac C, Gubler MC, Leverger G, Broyer M, Habib R. Delayed renal failure with extensive mesangiolysis following bone marrow transplantation. Kidney Int 1989; 35: 1336-44.
2. Cohen EP, Robbins MEC. Radiation nephropathy. Semin Nephrol 2003; 23: 486-99.
3. Moulder JE, Fish BL, Abrams RA. Renal toxicity following total body irradiation and syngeneic bone marrow transplantation. Transplantation 1987; 43: 589-92.
4. Cohen EP, Fish BL, Moulder JE. The renin-angiotensin system in experimental radiation nephropathy. J Lab Clin Med 2002; 139: 251-7.
5. Cohen EP. Radiation nephropathy. In: Davison AM, Cameron JS, Grünfeld JP, et al., Eds, Oxford Textbook of Clinical Nephrology. Oxford, Oxford University Press 2005; 1091-4.
6. Moulder JE, Cohen EP. Radiation-induced multi-organ involvement and failure: the contribution of radiation effects on the renal system. Br J Radiol Suppl 2005; 27: 82-8.
7. Moulder JE, Cohen EP. Future strategies for mitigation and treatment of chronic radiation-induced normal tissue injury. Sem Rad Onc 2007; 17: 141-8.
8. Lenarczyk M, Cohen EP, Fish BL, et al. Chronic oxidative stress as a mechanism for radiation nephropathy. Radiat Res 2009; 171: 164-72.
9. Baker JE, Fish BL, Su J, et al. 10 Gy total body irradiation increases risk of coronary sclerosis, degeneration of heart structure and function in a rat model. Int J Radiat Biol 2009; 85: 1089-110.
10. Moulder JE, Fish BL, Holcenberg JS, et al. Hepatic function and drug pharmacokinetics after total body irradiation plus bone marrow transplant. Int J Radiat Oncol Biol Phys 1990; 19: 1389-96.
11. Coleman CN, Blakely WF, Fike JR, Sun GX. Molecular and cellular biology of moderate-dose (1-10 Gy) radiation and potential mechanisms of radiation protection: Report of a workshop at Bethesda, Maryland, December 17-18, 2001. Radiat Res 2003; 159: 812-34.
12. Moulder JE, Fish BL, Cohen EP. Noncontinuous use of angiotensin converting enzyme inhibitors in the treatment of experimental bone marrow transplant nephropathy. Bone Marrow Transplant 1997; 19: 729-36.
13. Cohen EP, Fish BL, Moulder JE. Successful brief captopril treatment in radiation nephropathy. J Lab Clin Med 1997; 129: 536-47.
14. Moulder JE, Fish BL, Cohen EP. Dietary sodium modification and experimental radiation nephropathy. Int J Radiat Biol 2002; 79: 903-11.
15. Cohen EP, Molteni A, Hill P, et al. Captopril preserves function and ultrastructure in experimental radiation nephropathy. Lab Invest 1996; 75: 349-60.
16. Cohen EP, Lawton CA, Moulder JE. Bone marrow transplant nephropathy: Radiation nephritis revisited. Nephron 1995; 70: 217-22.
17. Cohen EP, Irving AA, Drobyski WR, et al. Captopril to mitigate chronic renal failure after hematopoietic stem cell transplantation: a randomized controlled trial. Int J Radiat Oncol Biol Phys 2008; 70: 1546-51.
18. Kobori H, Nangaku M, Navar LG, et al. The intrarenal reninangiotensin system: From physiology to the pathobiology of hypertension and kidney disease. Pharm Rev 2007; 59: 251-87.
19. Ghosh SN, Zhang R, Fish BL, et al. Renin-angiotensin system suppression mitigates experimental radiation pneumonitis Int J Radiat Oncol Biol Phys 2009; 75: 1528-36.
20. Ryu S, Kolozsvary A, Jenrow KA, Brown SL, Kim JH. Mitigation of radiation-induced optic neuropathy in rats by ACE inhibitor ramipril: importance of ramipril dose and treatment time. J Neuro-Oncol 2007; 82: 119-24.
21. Cohen EP, Fish BL, Sharma M, Li XA, Moulder JE. Role of the angiotensin II type-2 receptor in radiation nephropathy. Trans Res 2007; 150: 106-15.
22. Kobori H, Ozawa Y, Suzaki Y, et al. Intratubular angiotensinogen in hypertension and kidney diseases. Amer J Hyperten 2006; 19: 541-50.
23. Cohen EP, Fish BL, Moulder JE. The role of nitric oxide in radiation nephropathy. Arch Physiol Biochem 1996; 104: 200-6.
24. Wenzel U. Aldosterone and progression of renal disease. Curr Opin Nephrol Hypertens 2008; 17: 44-50.
25. Shimizu MH, Coimbra TM, de Araujo M, Menezes LF, Seguro AC. N-acetylcysteine attenuates the progression of chronic renal failure. Kidney Int 2005; 68: 2208-17.
26. Omata M, Taniguchi H, Koya D, et al. N-acetyl-seryl-aspartyllysyl-proline ameliorates the progression of renal dysfunction and fibrosis in WKY rats with established anti-glomerular basement membrane nephritis. J Amer Soc Nephrol 2006; 17: 674-85.
27. Peng H, Carretero OA, Liao TD, Peterson EL, Rhaleb NE. Role of N-acetyl-seryl-aspartyl-lysyl-proline in the antifibrotic and antiinflammatory effects of the angiotensin-converting enzyme inhibitor captopril in hypertension. Hypertension 2007; 49: 695-703.
28. Doggrell SA. Bradykinin B2 receptors as a target in diabetic nephropathy. Curr Opin Invest Drugs 2006; 7: 251-5.
29. Jaggi JS, Seshan SV, McDevitt MR, Sgouros G, Hyjek E, Scheinberg DA. Mitigation of radiation nephropathy after internal α-particle irradiation of kidneys. Int J Radiat Oncol Biol Phys 2006; 64: 1503-12.
30. Santos RAS, Ferreira AJ, Silva ACE. Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis. Exper Physiol 2008; 93: 519-27.
31. Shao Y, He M, Zhou L, et al. Chronic angiotensin (1-7) injection accelerates STZ-induced diabetic renal injury. Acta Pharm Sinica 2008; 29: 829-37.
32. Morita T, Churg J. Mesangiolysis. Kidney Int 1983; 24: 1-9.
33. Glatstein E, Fajardo LF, Brown JM. Radiation injury in the mouse kidney--Sequential light microscopic study. Int J Radiat Oncol Biol Phys 1977; 2: 933-43.
34. Robbins MEC, Jaenke RS, Bywaters T, et al. Sequential evaluation of radiation-induced glomerular ultrastructural changes in the pig kidney. Radiat Res 1993; 135: 351-64.
35. Nakayama T, Sato W, Kosugi T, et al. Endothelial injury due to eNOS deficiency accelerates the progression of chronic renal disease in the mouse. Am J Physiol Renal Physiol 2009; 296: F317-F27.
36. Verhagen AMG, Braam B, Boer P, Grone HJ, Koomans HA, Joles JA. Losartan-sensitive renal damage caused by chronic NOS inhibition does not involve renal angiotensin II concentrations. Kidney Int 1999; 56: 222-31.
37. Meyer TW, Anderson S, Rennke HG, Brenner BM. Reversing glomerular hypertension stabilizes established glomerular injury. Kidney Int 1987; 31: 752-9.
38. Remuzzi G, Benigni A, Remuzzi A. Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. J Clin Invest 2006; 116: 288-96.
39. Cohen EP, Regner K, Fish BL, Moulder JE. Stenotic glomerulotubular necks in radiation nephropathy. J Pathol 2000; 190: 484-8.
40. Moulder JE, Fish BL, Cohen EP. Treatment of radiation nephropathy with ACE inhibitors. Int J Radiat Oncol Biol Phys 1993; 27: 93-9.
41. Brewster UC, Perazella MA. The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease. Am J Med 2004; 116: 263-72.
42. Sebekova K, Lill M, Boor P, Heidland A, Amann K. Functional and partial morphological regression of established renal injury in the obese zucker rat by blockade of the renin-angiotensin system. Am J Nephrol 2009; 29: 164-70.
43. Moulder JE, Fish BL, Cohen EP. Brief pharmacologic intervention in experimental radiation nephropathy. Radiat Res 1998; 150: 535-41.
44. Zhao W, Diz DI, Robbins ME. Oxidative damage pathways in relation to normal tissue injury. Br J Radiol 2007; 80 S23-S31.
45. Sachse A, Wolf G. Angiotensin II-Induced reactive oxygen species and the kidney. J Amer Soc Nephrol 2007; 18: 2439-46.
46. Cohen EP, Fish BL, Irving AA, Rajapurkar MM, Shah SV, Moulder JE. Radiation nephropathy is not mitigated by antagonists of oxidative stress. Radiat Res 2009; 172: 260-4.
47. Lawton CA, Cohen EP, Murray KJ, et al. Long-term results of selective renal shielding in patients undergoing total body irradiation in preparation for bone marrow transplantation. Bone Marrow Transplant 1997; 12: 1069-74.
48. Miralbell R, Bieri S, Mermillod B, et al. Renal toxicity after allogeneic bone marrow transplantation: The combined effects of total-body irradiation and graft-versus-host disease. J Clin Oncol 1996; 14: 579-85.
49. Sieber F, Muir SA, Cohen EP, et al. High-dose selenium for the mitigation of radiation injury: a pilot study in a rat model. Radiat Res 2009; 171: 368-73.